| Bioactivity | 1-(a-D-ribofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | ||||||||||||
| Name | 1-(a-D-ribofuranosyl)uracil | ||||||||||||
| CAS | 3258-07-9 | ||||||||||||
| Formula | C9H12N2O6 | ||||||||||||
| Molar Mass | 244.20 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
1-(a-D-ribofuranosyl)uracil
CAS: 3258-07-9 F: C9H12N2O6 W: 244.20
1-(a-D-ribofuranosyl)uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targe
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.